Zobrazeno 1 - 10
of 93
pro vyhledávání: '"HOU‑QUAN TAO"'
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Digestive system malignancies, the most common types of cancer and a major cause of death in the worldwide, are generally characterized by high morbidity, insidious symptoms and poor prognosis. NLRP3 inflammasome, the most studied inflammasome member
Externí odkaz:
https://doaj.org/article/7593be4742d941228caaa1c88576c0c8
Autor:
Xu-Jun He, Ying-Yu Ma, Sheng Yu, Xiao-Ting Jiang, Yi-Ding Lu, Liang Tao, Hua-Ping Wang, Zhi-Ming Hu, Hou-Quan Tao
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-1 (2022)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/1471-2407-14-218.
Externí odkaz:
https://doaj.org/article/3cfdbb936cde4b9d91e68488720c2438
Autor:
Ying-Yu Ma, Tian-Pei Guan, Hai-Bo Yao, Sheng Yu, Le-Gao Chen, Ying-Jie Xia, Xu-Jun He, Hui-Ju Wang, Xiao-Ting Jiang, Hou-Quan Tao
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e55019 (2013)
Recently, there have been a number of studies on the association between MDM2 (Murine Double Minute 2) 309 polymorphism and ovarian cancer risk. However, the results of previous reports remain controversial and ambiguous. Thus, we performed a meta-an
Externí odkaz:
https://doaj.org/article/bc560d7ee3274122aafbe1366c91748b
Autor:
Zhen-Hua Liu, Bo-Wen Zhu, Min Shi, Yu-Rong Qu, Xun-Jun He, Hong-Ling Yuan, Jie Ma, Wei Li, Dan-Dan Zhao, Zheng-Chuang Liu, Bao-Ming Wang, Chun-Yang Wang, Hou-Quan Tao, Tong-Hui Ma
Publikováno v:
World journal of gastrointestinal oncology. 14(8)
Approximately half of all new cases of gastric cancer (GC) and related deaths occur in China. More than 80% of patients with GC are diagnosed at an advanced stage, which results in poor prognosis. AlthoughTo identify the profile of fusions involving
Autor:
Hou‑Quan Tao, Jun‑Gang Luo, Xujun He, Jian‑Zhong Chen, Shi‑Bin Jiang, Xiao‑Ting Jiang, Zheng‑Chuang Liu, Ying‑Jie Xia, Liang Wang
Publikováno v:
Molecular Medicine Reports. 16:6882-6889
Prolyl hydroxylase 3 (PHD3) is widely accepted as a tumor suppressor; however, the expression of PHD3 in various cancer types remains controversial. The present study aimed to investigate the association between PHD3 expression and the clinicopatholo
Publikováno v:
The Journal of pharmacy and pharmacologyReferences. 72(2)
Objectives This study is designed to investigate the effects and mechanisms of sinomenine (Sin) in stress load-induced heart failure in mice. Methods We used aortic constriction (AB) to cause pressure overload as our heart failure model. Sin was rece
Publikováno v:
Journal of cellular biochemistryREFERENCES.
Pancreatic cancer is always diagnosed at an advanced stage. Hence, chemotherapy becomes the best choice for patients. Therefore, new anticancer drugs for pancreatic cancer are needed. Riluzole (RIL) is mainly used to treat amyotrophic lateral scleros
Publikováno v:
Journal of applied biomedicine. 19(3)
To study the effect of sinomenine (Sin) on isoproterenol (Iso, β-agonist)-induced cardiac hypertrophy (CH), we set up four mouse groups: control, Iso model, Iso+metoprolol (Met, β blocker) 60 mg/kg and Iso+Sin 120 mg/kg. CH was induced by Iso (s.c.
Autor:
Dong Chen, Ke Hao, Meng-Hua Zhu, Zhen Wang, Wei Zhang, Jing-Jing Zeng, Hou-Quan Tao, You-Min Ying, Kai-Qiang Li, Bingyu Chen, Xiaozhou Mou, Meng-Meng Jiang, Xu-Jun He, Jian-Xin Lyu
Publikováno v:
Chinese Journal of Natural Medicines. 14:922-930
Marsdeniae tenacissimae extract (MTE), commonly known as Xiao-Ai-Ping in China, is a traditional Chinese herb medicine capable of inhibiting proliferation and metastasis and boosting apoptosis in various cancer cells. However, little is known about t
Autor:
Tonghui Ma, Xujun He, Ji Xu, Wen-Juan Xu, Haibin Ni, Liping Jiang, Zhengchuang Liu, Jie Ma, Dong-Sheng Huang, Yiping Mou, Lu Wang, Ying-Jie Xia, Guo-Qing Ru, Xiao-Ting Jiang, Guocai Lv, Hou-Quan Tao, Zhong-kuo Zhao
Publikováno v:
Oncotarget
// Xujun He 1 , Zhengchuang Liu 1 , Yingjie Xia 1 , Ji Xu 1, 2 , Guocai Lv 3, 4 , Lu Wang 1 , Tonghui Ma 1 , Liping Jiang 1 , Yiping Mou 1, 2 , Xiaoting Jiang 1 , Jie Ma 5, 6 , Zhongkuo Zhao 1, 2 , Haibin Ni 7 , Wenjuan Xu 5, 6 , Guoqing Ru 5, 6 , Do